Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
"*" indicates required fields
Efficiency Gains
Drive faster submissions by automating and augmenting critical workflows, including reducing manual document authoring by up to 70-80%.
Cost Savings
Automate manual processes, including medical writing authoring and management, to reduce labor and error-related expenses.
Audit and Inspection Readiness
Strengthen global compliance with enhanced traceability and inspection readiness via centralized document management and intelligent workflows.
Quality and Consistency
Produce higher-quality regulatory documents through AI-assisted content generation that ensure more consistent, reliable outcomes at scale.


AI-Assisted Report Authoring
Harness AI to automatically gather, synthesize, and contextualize information from multiple sources and pre-populate report templates.

Intelligent Report Reuse
Enable faster, more consistent report creation by intelligently updating sections with the latest information from previously authored reports.

Collaborative Review
Support secure multi-author collaboration with configurable review workflows, version control, electronic approvals, and complete audit trails.

Pharmacovigilance Agreement (PVA) Management
Simplify the creation, review, approval, and maintenance of PVAs using standardized templates and intelligent workflow automation.

Pharmacovigilance System Master File (PSMF) Management
Maintain inspection-ready PSMFs through centralized content management, automated change tracking, and lifecycle controls.

Operational Dashboards
Gain real-time visibility into document status, reporting timelines, submission readiness, and operational performance.
"*" indicates required fields

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved